Persistent Systems Achieves Databricks Brickbuilder Specialization for Healthcare and Life Sciences
Persistent Systems, a global leader in digital engineering and enterprise modernization, has recently achieved the Databricks Brickbuilder specialization for the healthcare and life sciences sectors. This important recognition underscores the company’s ability to deliver production-ready data and AI solutions tailored for regulated environments.
The pressure on healthcare and life sciences organizations to expedite clinical trials and shorten drug discovery timelines is mounting. Existing architectural frameworks often struggle to integrate diverse data sets including clinical records, genomics, imaging, and patient data. By leveraging the Databricks Data Intelligence platform, Persistent Systems aims to unify these data sources into a governed framework ready for AI application. This capability enhances clinical trial design, facilitates faster cohort identification, aids in biomarker discovery, and creates scalable clinical data platforms.
Accelerating innovation in these critical fields requires the ability to transition from isolated pilot projects to enterprise-level AI applications, ensuring accuracy, governance, and interoperability across clinical, research, commercial, and operational workflows. Persistent Systems utilizes key technologies from Databricks to achieve these objectives effectively. Delta Lake provides a reliable database essential for AI compliance, Unity Catalog enables smart governance and data monitoring, while Mosaic AI supports secure model development and deployment for various use cases including patient risk prediction, clinical trial optimization, and pharmacovigilance.
The collaboration between Persistent and Databricks is evolving further through co-creation initiatives and market deployment strategies targeted at achieving measurable commercial outcomes across the healthcare and life sciences ecosystem. This impact is evident in real-world applications, such as Persistent’s assistance to a contract research organization in boosting its trial success rates, and supporting a leading player in the scientific instruments and medical devices sector to innovate more rapidly using the Databricks platform.
Persistent has also established itself as a Silver Global Systems Integrator partner for Databricks, with over 900 certifications and a burgeoning portfolio of accelerators on the Databricks Data Intelligence platform. Key executives from Persistent voiced their insights on the significance of this specialization. Ganesh Nathella, Executive Vice President and General Manager of HLS Business at Persistent, stated, “For healthcare and life sciences, the focus is shifting from merely accessing data to leveraging it in clinical, research, and operational settings. Achieving Databricks Brickbuilder specialization reflects our advancements in building the necessary capabilities to address this change.”
At the same time, Sameer Dixit, Corporate Vice President of Data and AI Integration at Persistent, emphasized, “Data preparation is crucial for developing AI in healthcare and life sciences, where organizations must integrate various data sets. At Persistent, we are crafting enterprise-level, governed, and scalable data and AI solutions on modern platforms, notably Databricks.” Josh Meyer, Global Head of Partner Solutions and Industry GTM at Databricks added, “The achievement of Databricks Brickbuilder specialization by Persistent showcases their proven ability to translate data and AI into tangible impacts for the industry.”
In summary, Persistent Systems stands at the forefront of digital transformation in healthcare and life sciences, ready to meet the challenges of an industry undergoing rapid evolution. Through leveraging advanced data strategies and partnerships, they are set to improve decision-making, accelerate innovation, and ultimately enhance patient outcomes in regulated environments. This commitment to excellence and progress in technology not only strengthens their position in the market but also emphasizes their role in shaping the future of healthcare and life sciences.
The pressure on healthcare and life sciences organizations to expedite clinical trials and shorten drug discovery timelines is mounting. Existing architectural frameworks often struggle to integrate diverse data sets including clinical records, genomics, imaging, and patient data. By leveraging the Databricks Data Intelligence platform, Persistent Systems aims to unify these data sources into a governed framework ready for AI application. This capability enhances clinical trial design, facilitates faster cohort identification, aids in biomarker discovery, and creates scalable clinical data platforms.
Accelerating innovation in these critical fields requires the ability to transition from isolated pilot projects to enterprise-level AI applications, ensuring accuracy, governance, and interoperability across clinical, research, commercial, and operational workflows. Persistent Systems utilizes key technologies from Databricks to achieve these objectives effectively. Delta Lake provides a reliable database essential for AI compliance, Unity Catalog enables smart governance and data monitoring, while Mosaic AI supports secure model development and deployment for various use cases including patient risk prediction, clinical trial optimization, and pharmacovigilance.
The collaboration between Persistent and Databricks is evolving further through co-creation initiatives and market deployment strategies targeted at achieving measurable commercial outcomes across the healthcare and life sciences ecosystem. This impact is evident in real-world applications, such as Persistent’s assistance to a contract research organization in boosting its trial success rates, and supporting a leading player in the scientific instruments and medical devices sector to innovate more rapidly using the Databricks platform.
Persistent has also established itself as a Silver Global Systems Integrator partner for Databricks, with over 900 certifications and a burgeoning portfolio of accelerators on the Databricks Data Intelligence platform. Key executives from Persistent voiced their insights on the significance of this specialization. Ganesh Nathella, Executive Vice President and General Manager of HLS Business at Persistent, stated, “For healthcare and life sciences, the focus is shifting from merely accessing data to leveraging it in clinical, research, and operational settings. Achieving Databricks Brickbuilder specialization reflects our advancements in building the necessary capabilities to address this change.”
At the same time, Sameer Dixit, Corporate Vice President of Data and AI Integration at Persistent, emphasized, “Data preparation is crucial for developing AI in healthcare and life sciences, where organizations must integrate various data sets. At Persistent, we are crafting enterprise-level, governed, and scalable data and AI solutions on modern platforms, notably Databricks.” Josh Meyer, Global Head of Partner Solutions and Industry GTM at Databricks added, “The achievement of Databricks Brickbuilder specialization by Persistent showcases their proven ability to translate data and AI into tangible impacts for the industry.”
In summary, Persistent Systems stands at the forefront of digital transformation in healthcare and life sciences, ready to meet the challenges of an industry undergoing rapid evolution. Through leveraging advanced data strategies and partnerships, they are set to improve decision-making, accelerate innovation, and ultimately enhance patient outcomes in regulated environments. This commitment to excellence and progress in technology not only strengthens their position in the market but also emphasizes their role in shaping the future of healthcare and life sciences.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.